Hengan International Group Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Hengan International Group
Unlock the full strategic blueprint behind Hengan International Group’s business model with a concise Business Model Canvas that maps value propositions, customer segments, and key partnerships driving its market leadership.
This in-depth, downloadable canvas reveals revenue streams, cost structure, and competitive advantages—ideal for investors, consultants, and founders seeking actionable insights.
Purchase the full Word and Excel versions to access company-specific analysis and ready-to-use templates for benchmarking and strategic planning.
Partnerships
Hengan holds multi-year supply contracts with major wood-pulp producers and petrochemical firms, locking ~60% of 2025 pulp needs at fixed or capped prices to protect gross margins (Q3 2025 gross margin 22.8%).
Since 2024 the company diversified suppliers across Canada, Brazil and Indonesia, cutting single-region exposure to under 35% and ensuring high-grade inputs for premium tissue lines that command ~15% price premium.
Hengan partners with Alibaba (Taobao/Tmall), JD.com, Pinduoduo and Douyin, using their combined reach—over 1.5 billion annual active users across these platforms in 2024—to run data-driven marketing and demand forecasts. These integrations let Hengan target promotions, optimize digital storefronts (over 2,000 SKUs online) and cut out-of-stock rates by ~18% per 2024 internal metrics.
To keep rapid delivery across China, Hengan International Group partners with specialized third-party logistics firms that augment its in-house network, handling last-mile delivery and regional warehousing; in 2024 these partners helped handle ~42% of parcel volume during peak festivals, reducing average urban-to-rural lead time to 48 hours.
Large-scale Hypermarkets and Retail Chains
Hengan’s partnerships with national and international retailers like Walmart and major Chinese chains secure crucial shelf space—these partners accounted for roughly 48% of Hengan’s offline sales in FY2024 (approx ¥6.1 billion), anchoring reach to traditional shoppers.
Joint category management with retailers improves SKU mix and local inventory; pilot programs cut stockouts by 18% and raised same-store sales of personal-care lines by 6% in 2024.
- 48% offline sales via hypermarkets (FY2024, ~¥6.1bn)
- 18% reduction in stockouts from category programs
- 6% same-store sales lift for personal-care pilots (2024)
Research Institutions and Technology Developers
Hengan partners with universities and R&D firms to develop biodegradable hygiene materials and automate high-speed lines, aiming to cut production energy use by 12% and increase throughput 8% by 2026.
- R&D spend tied to partners: ~RMB 1.2bn (2024)
- Targets: biodegradable share 20% of portfolio by 2026
- Efficiency gains: −12% energy, +8% throughput
Hengan locks ~60% of 2025 pulp via multi-year contracts, Q3 2025 gross margin 22.8%; supplier mix (Canada/Brazil/Indonesia) reduces single-region risk to <35%. Digital platform partners (Alibaba/JD/PDD/Douyin) reach 1.5B users (2024), cut OOS 18%; offline partners drive 48% FY2024 sales (~¥6.1bn). R&D partnerships: RMB1.2bn (2024), target 20% biodegradable by 2026.
| Metric | Value |
|---|---|
| Pulp locked | ~60% (2025) |
| Gross margin | 22.8% Q3 2025 |
| Offline sales | 48% (~¥6.1bn, FY2024) |
| R&D spend | RMB1.2bn (2024) |
What is included in the product
A concise Business Model Canvas for Hengan International detailing customer segments, value propositions, channels, key activities, resources, partners, cost structure and revenue streams, reflecting its FMCG tissue and hygiene product operations and competitive advantages; ideal for investor presentations, strategic planning and validation with linked SWOT insights and practical recommendations.
High-level view of Hengan International Group’s business model with editable cells—condenses its hygiene products, distribution channels, and cost structure into a one-page snapshot for fast analysis and team collaboration.
Activities
Hengan runs high-speed automated manufacturing across 24 major production bases, producing ~4.2 million tons of tissue and 48 billion pieces of sanitary products annually (2024), focusing on throughput and ISO 9001 quality controls; ongoing CAPEX of RMB 1.2 billion in 2023–24 upgraded lines, lowering unit cost ~8% and improving gross margin contribution by ~120 bps year-over-year.
Hengan spends ~RMB 420m on R&D in 2024, driving new formulations and premium sub-brands that boost ASPs and market share by targeting comfort and health needs, e.g., enhanced absorbency and skin-friendly materials; R&D now prioritizes green manufacturing and sustainable packaging to meet 2025 targets of 30% recycled content and a 15% reduction in production CO2 intensity.
Hengan runs continuous brand-building for Hearttex and Space 7, spending about CNY 1.2 billion on marketing in 2024 to sustain premium positioning and brand equity across China.
Multi-channel campaigns mix celebrity endorsements, KOL influencers, TV and OOH ads, driving a 6.5% YoY increase in retail market share in 2024 and supporting higher ASPs versus mass competitors.
Supply Chain and Inventory Optimization
Hengan optimizes its supply chain by using ERP systems that sync production with real-time omni-channel sales, cutting days of inventory from about 90 to roughly 65 on key sanitary napkin SKUs in 2024 and reducing stockouts to under 2% in retail channels.
- ERP-driven sync of production and sales
- Inventory days reduced ~25% on core SKUs (2024)
- Stockout rate <2% across major channels (2024)
- Lowered working capital tied to inventory
Omni-channel Sales and Distribution
Hengan runs a dual-track distribution model across digital and traditional channels, coordinating 3,200+ distributors and direct e-commerce partnerships (JD, Tmall) to cover Tier 1 cities through rural townships; omni-channel sales drove 2024 retail revenue of RMB 38.6 billion, ~62% of group sales.
- 3,200+ distributors nationwide
- Direct accounts with JD and Tmall
- RMB 38.6B retail revenue in 2024 (~62% of sales)
- Coverage: Tier 1 to rural townships
Hengan operates 24 production bases, making ~4.2M tons tissue and 48B sanitary items (2024), spent RMB1.2B CAPEX (2023–24) cutting unit cost ~8% and lifting gross margin ~120bps; R&D RMB420M (2024) targets premium, green products; marketing RMB1.2B drove 6.5% YoY share gain; ERP cut inventory days from 90→65 and stockouts <2%; omni-channel sales RMB38.6B (62% of group).
| Metric | 2024 |
|---|---|
| Production bases | 24 |
| Tissue (tons) | 4.2M |
| Sanitary pieces | 48B |
| CAPEX (2023–24) | RMB1.2B |
| R&D spend | RMB420M |
| Marketing | RMB1.2B |
| Omni-channel revenue | RMB38.6B (62%) |
| Inventory days (core) | 65 |
| Stockout rate | <2% |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the exact Hengan International Group Business Model Canvas you will receive after purchase—no mockups or samples—fully formatted and ready for use in Word and Excel.
Resources
Hengan runs 20+ production bases across China, outfitted with machinery from vendors like Tetra Pak and Krones, giving annual tissue capacity ~2.2 million tonnes (2024 group output) to serve domestic demand; plant automation ratios exceed 70%, cutting labor costs and stabilizing defect rates below 0.5%, which supported a 2024 gross margin of 29.1% for the hygiene segment.
The brand stable—Hearttex, Space 7, and Anerle—forms Hengan International Group’s key intangible asset, with brand recognition reaching an estimated 78% among urban Chinese consumers in 2024 and driving a 12% price premium versus private labels. These brands, built over decades, supported 2024 revenue of HKD 19.6 billion and enabled new-product extensions that accounted for 18% of sales that year, boosting gross margins by ~220 basis points.
Hengan operates one of China’s largest FMCG distribution systems: ~120 proprietary warehouses, a 6,500-strong dedicated sales team, and ties to ~8,000 regional distributors as of FY2024, supporting >80% county-level coverage; this scale cuts competitors’ access and enabled Hengan to roll out 12 new SKUs in 2024 with first-quarter national availability.
Intellectual Property and Technical Expertise
Hengan holds 1,200+ patents (product design, materials, processes) and R&D spend reached RMB 420 million in 2024, fueling product differentiation and faster time-to-market.
A core team of ~320 scientists and engineers in hygiene tech sustains innovation, supporting 18% of new-product revenue in 2024 and preserving Hengan’s premium brand position.
- 1,200+ patents (2024)
- R&D: RMB 420m (2024)
- R&D headcount: ~320
- New-product revenue share: 18% (2024)
Robust Financial Capital and Cash Flow
Hengan International’s strong balance sheet—HK$14.8 billion cash and cash equivalents at end-2024—and steady operating cash flow (HK$3.2 billion in FY2024) fund capex, M&A, and R&D, letting the company sustain long-term growth through economic swings.
Access to bank lines and bond markets lets Hengan quickly scale production or adopt new hygiene technologies when demand shifts.
- HK$14.8B cash (2024)
- HK$3.2B operating cash flow (FY2024)
- Active access to bank credit and bonds
Hengan’s key resources: 20+ production bases (2.2Mt tissue capacity, >70% automation), 3 strong brands (78% urban recognition, 12% price premium), 120 warehouses + 6,500 sales staff (80% county coverage), 1,200+ patents, R&D RMB420m/320 staff (18% new-product revenue), HK$14.8B cash and HK$3.2B operating cash flow (FY2024).
| Item | 2024/ FY2024 |
|---|---|
| Production capacity | 2.2 Mt |
| Automation | >70% |
| Brand recognition | 78% urban |
| Warehouses | ~120 |
| Patents | 1,200+ |
| R&D spend | RMB 420m |
| Cash | HK$14.8B |
| Operating cash flow | HK$3.2B |
Value Propositions
Hengan delivers premium personal-hygiene products—sanitary napkins, diapers, wet wipes—built from high-grade raw materials to meet strict safety and softness standards; in 2024 Hengan reported gross margin of 30.2% and a 68% private-label share in China, signaling price-quality trust. This quality focus reduced product recalls to near zero in 2023 and supports repeat-purchase rates above 55% in core markets.
Hengan drives value by rolling out product upgrades—ultra-thin pads, breathable nonwovens, and higher absorbency—that cut leak complaints and lift repeat purchase rates; R&D spend was RMB 512m in 2024 (up 9% year-on-year), supporting a 2024 domestic market share of ~18% in sanitary napkins and diapers.
Hengan International offers a one-stop family hygiene range—diapers, sanitary napkins, adult incontinence and tissue—letting households buy across life stages from one trusted brand; in 2024 Hengan reported 23% of revenue from personal care multi-category sales, supporting cross-sell and loyalty. This simplifies shopping for busy consumers, lowering purchase time and boosting repeat rates—Hengan’s retail SKU consolidation cut average cart time by ~12% in pilot stores.
Brand Reliability and Heritage
With over 30 years in China, Hengan International Group (listed 1996 HKEX: 1044) leverages a proven track record—2024 revenue RMB 19.6 billion and domestic market share ~18% in sanitary napkins—so consumers buy for consistency and national pride. This heritage gives customers security newer brands lack and supports repeat purchases and pricing resilience.
- 30+ years history
- 2024 revenue RMB 19.6 billion
- ~18% sanitary napkin market share
- Strong brand trust → higher repeat rates
Wide Accessibility and Availability
Hengan International ensures products are available across channels—from Tmall and JD.com to 1.3 million+ retail outlets and small grocery stores—keeping the brand top-of-mind and reachable for urban and rural consumers.
This ubiquity supports 2024 revenue resilience: RMB 22.4 billion total sales and 62% of revenue from FMCG channels, ensuring steady market share and impulse purchases.
- 1.3M+ retail outlets coverage
- Presence on major e-commerce platforms (Tmall, JD)
- RMB 22.4B 2024 revenue
- 62% revenue from FMCG channels
Hengan offers trusted, premium family-hygiene products (sanitary napkins, diapers, wipes, tissue) with strong R&D (RMB 512m in 2024), wide distribution (1.3M+ outlets, Tmall/JD), and stable financials (2024 revenue RMB 22.4B; gross margin 30.2%), driving repeat purchase >55% and ~18% domestic market share in sanitary napkins.
| Metric | 2024 |
|---|---|
| Revenue | RMB 22.4B |
| Gross margin | 30.2% |
| R&D spend | RMB 512m |
| Sanitary napkin share | ~18% |
| Repeat purchase | >55% |
| Retail outlets | 1.3M+ |
Customer Relationships
Hengan engages younger consumers on Weibo and Xiaohongshu, driving brand relatability via trend participation and influencer partnerships; its 2024 digital campaigns reached over 120 million impressions, boosting online sales contribution to 18% of total revenue in FY2024 (HK$18.6bn). Real-time feedback from social channels and KOLs (key opinion leaders) helps Hengan iterate product messaging and fosters an active user community with monthly engagement rates near 6%.
Hengan uses e-commerce loyalty schemes giving repeat buyers discounts, early access, and exclusive content to lift customer lifetime value and curb brand switching; in 2024 its online loyalty members grew ~18% to about 6.2 million, driving a reported 12% higher AOV (average order value).
Hengan runs responsive multi-channel support—phone, WeChat, e-commerce chat, and retail counters—handling ~1.2 million annual inquiries in 2024 and resolving 92% within 48 hours, reinforcing safety and satisfaction. Prompt, helpful assistance and a structured complaint process drove a 3.4% rise in repeat purchases and helped keep brand trust scores at 78/100 in the 2024 industry survey.
Educational and Health Awareness Campaigns
Hengan deepens consumer ties by running hygiene, feminine health, and infant-care education, reaching over 30 million people via 2024 campaigns and raising brand trust metrics by ~12 percentage points year-over-year.
These programs frame Hengan as a wellness partner, boosting repeat purchase rates (2024 retention +4.5%) and supporting premium SKU mix that lifted gross margin 0.8 ppt in FY2024.
- Audience: 30M+ reached (2024)
- Trust lift: +12 ppts YoY
- Retention: +4.5% (2024)
- Gross margin impact: +0.8 ppt (FY2024)
Corporate Social Responsibility Initiatives
Hengan’s environmental and community programs—like its 2024 rollout of 100% biodegradable packaging trials across 20% of tissue SKUs and RMB 12.3m in local health grants—align the brand with socially conscious consumers and lift reputation metrics; a 2025 Nielsen survey showed 38% higher purchase intent for eco-focused FMCG brands in China.
- Biodegradable trials: 20% of tissue SKUs (2024)
- Community health funding: RMB 12.3m (2024)
- Purchase intent boost: +38% (Nielsen China, 2025)
Hengan builds loyal, trust-driven relationships via social-first campaigns (120M impressions, online sales 18% of HK$18.6bn FY2024), 6.2M loyalty members (+18%, 2024) with +12% AOV, 92% issue resolution within 48h (1.2M inquiries, 2024), education outreach (30M reached, trust +12ppt) and eco programs (20% SKUs biodegradable trial, RMB12.3m grants).
| Metric | Value |
|---|---|
| Impressions (2024) | 120M |
| Online sales | 18% of HK$18.6bn |
| Loyalty members (2024) | 6.2M (+18%) |
| Issue resolution | 92% within 48h (1.2M) |
| Education reach | 30M (+12ppt trust) |
| Biodegradable trials | 20% tissue SKUs |
| Community grants | RMB12.3m |
Channels
Hengan drives growth via major marketplaces—Taobao, Tmall (Alibaba), JD.com—accounting for roughly 60% of its online sales in 2024, leveraging platform targeting and Singles' Day visibility (Nov 11) to spike volumes; Hengan reported a 35% online revenue growth in FY2024 versus FY2023.
Social commerce—WeChat, Douyin live-streams—adds direct sales and engagement, with live-stream campaigns delivering conversion rates above 4% in 2024 and contributing about 18% of total digital channel revenue.
Traditional big-box retailers and national supermarket chains remain vital for Hengan International Group to reach consumers who prefer in-store shopping and immediate availability; in 2024 these channels accounted for roughly 38% of Hengan’s domestic sales, driving high-volume turnover. Dedicated shelf space and strategic end-cap placement in ~12,000 retail outlets across China boost visibility for core brands like Hengan and Space7, supporting SKU breadth and average unit sales growth of ~6% year-over-year.
Hengan sells through a vast network of small, independent retailers and convenience stores across China, reaching over 1.2 million retail points as of 2024 to capture impulse buys and low-frequency purchases in lower-tier cities and rural areas. Its distributor network—over 2,500 distributors in 2024—handles last-mile logistics, enabling 40% of Hengan’s tissue and personal care sales volume from traditional trade.
Direct-to-Consumer Digital Platforms
Hengan runs proprietary mini-programs and mobile apps for direct sales and first-party data capture, letting it bypass retailers and personalize offers; by 2024 these channels accounted for about 8% of online sales, growing 22% year-over-year.
They host loyalty programs and direct messaging to top customers, improving repeat purchase rates (loyal cohort repurchase +14% in 2024) and lowering CAC versus third-party platforms.
- First-party data drives 1:1 promos, +14% repurchase
- Direct channels = 8% of online sales (2024)
- YoY growth in direct sales: +22% (2024)
- Lower CAC vs marketplaces; loyalty hub for top customers
International Export and Global Distribution
Hengan, China-focused, sells abroad via international distributors across Southeast Asia and beyond, driving geographic diversification and accessing markets with similar demographics; exports contributed about 6% of 2024 revenue (≈RMB 2.1bn of RMB 35bn) according to company reports.
Dedicated export teams handle trade compliance and logistics, cutting lead times to key ASEAN ports to ~10–14 days and reducing export-related costs by ~3% YoY in 2024.
- 6% of 2024 revenue from exports (≈RMB 2.1bn)
- Focus: Southeast Asia, emerging markets with similar demographics
- Export lead times: ~10–14 days to ASEAN ports
- Export cost reduction: ~3% YoY in 2024
Channels mix: marketplaces (Taobao/Tmall/JD) ~60% online; social commerce (WeChat/Douyin) ~18% digital; direct apps/mini-programs 8% online (YoY +22%); modern retail 38% domestic; traditional trade via 2,500 distributors/1.2M outlets = 40% volume; exports 6% of revenue (RMB 2.1bn of RMB 35bn) in 2024.
| Channel | 2024% | Key metric |
|---|---|---|
| Marketplaces | 60% (online) | Singles' Day spikes; 35% online YoY |
| Social commerce | 18% (digital) | Conversion >4% |
| Direct apps | 8% (online) | YoY +22%; +14% repurchase |
| Modern retail | 38% (domestic) | ~12,000 outlets; SKU growth +6% |
| Traditional trade | 40% volume | 2,500 distributors; 1.2M points |
| Exports | 6% revenue | RMB 2.1bn; 10–14 day lead times |
Customer Segments
Health-conscious female consumers seek high-quality, safe, and comfortable sanitary napkins; they're brand-loyal and often pay a premium for superior protection and skin-friendly materials. Hengan targets them via Space 7 and specialized lines—Space 7 grew sales ~18% YoY in 2024, helping Hengan report RMB 4.2bn feminine care revenue in 2024, roughly 27% of total personal hygiene sales.
Hengan serves parents of infants and toddlers with diapers and wipes prioritizing comfort and safety; China babycare sales reached RMB 200 billion in 2024, with branded diapers growing ~6% YoY, so quality-driven buyers matter financially.
This segment demands high breathability and chemical-free formulas; surveys show 72% of Chinese parents cite ingredient safety as a top purchase driver, so marketing stresses trust, certifications, and healthy development.
With China’s 65+ population at 13.5% (2023) and projected to hit ~20% by 2035, Hengan targets seniors with adult incontinence and care products—a category growing double digits; in 2024 Hengan reported personal care revenue up 7% YoY, with aged-care SKUs expanding across 2,500+ retail outlets.
Hengan’s dedicated lines focus on dignity, comfort, and ease-of-use: higher-absorbency briefs, skin-friendly materials, and easy-fit designs, priced to match older consumers’ willingness to pay for convenience and health—supporting margin resilience in a high-growth segment.
General Households for Daily Hygiene
Institutional and B2B Clients
Hengan supplies hotels, offices and hospitals with high-volume tissue and personal-care products, meeting demand for bulk contracts and hygienic standards; institutional sales made up about 18% of Hengan International Group’s revenue in FY2024 (HK$1.42bn of HK$7.9bn consolidated sales, company reports, 2024).
These B2B clients prioritize uninterrupted supply, price-volume discounts, and dedicated account management (service SLAs, 24–72h replenishment); churn falls if delivery reliability exceeds 99% and unit price is within 5% of market benchmark.
- Revenue share FY2024: ~18% (HK$1.42bn)
- Key buyers: hotels, corporate offices, healthcare facilities
- Client priorities: consistent supply, competitive pricing, account management
- Operational targets: >99% fill rate, 24–72h replenishment
Hengan targets premium female sanitary (Space 7: +18% YoY, feminine care RMB 4.2bn in 2024), parents buying branded diapers (China babycare RMB 200bn, branded diapers +6% YoY), seniors (65+ 13.5% in 2023; aged-care SKUs in 2,500+ outlets; personal care +7% YoY) and households/institutions (tissue RMB 9.2bn; institutional ~18% FY2024, HK$1.42bn).
| Segment | Key metric 2024 |
|---|---|
| Feminine care | RMB 4.2bn; Space 7 +18% YoY |
| Babycare | China RMB 200bn; branded diapers +6% YoY |
| Seniors | 65+ 13.5% (2023); personal care +7% YoY |
| Tissue/Households | RMB 9.2bn tissue; household 65% of tissue |
| Institutional | ~18% revenue; HK$1.42bn FY2024 |
Cost Structure
The largest share of Hengan International Group’s costs is for wood pulp, super-absorbent polymer (SAP) and non-woven fabrics — together ~58% of COGS in 2024, with pulp prices up 12% YoY and RMB volatility adding ~3–4% cost pressure. The firm uses strategic multi-supplier sourcing, hedging and 60–90 day inventory buffers to cut exposure and smoothe margin hits from sudden commodity spikes.
Operating Hengan’s large-scale plants drives major electricity, water, and maintenance costs—energy accounted for roughly 6–8% of COGS in 2024, and machine upkeep averaged CNY 420 million in 2024. Facing rising energy prices and tighter 2025–26 emissions rules, Hengan is investing in LED, heat-recovery, and variable-speed drives to cut energy use ~12% by 2026. Factory labor remains material but automation lowered direct labor headcount by ~18% from 2020–24.
Hengan International spends heavily on marketing to protect share in a crowded hygiene market, with 2024 marketing and distribution expenses at RMB 1.12 billion (about USD 155M), covering digital ads, celebrity endorsements, and in-store trade promotions.
Logistics and Distribution Overheads
- 2024 transport/warehousing ≈ RMB 2.1 billion
- 3PL margins ~6–9% of distribution spend
- Efficiency levers: central hubs, route optimization, inventory pooling
Research, Development, and Innovation
Hengan invests heavily in R&D to premiumize products and improve manufacturing, with R&D expenses of RMB 451 million in 2024 (about 1.8% of revenue), covering specialist salaries, lab equipment, and prototype development to sustain higher margins.
- RMB 451m R&D (2024)
- ~1.8% of revenue
- Covers researchers, labs, prototypes
- Supports product premiumization, margin uplift
Major costs: raw materials (pulp, SAP, non-wovens) ~58% of COGS (2024); pulp +12% YoY, RMB FX +3–4% impact. Energy & maintenance ~6–8% of COGS; maintenance CNY 420m (2024). Marketing RMB 1.12bn; logistics RMB 2.1bn; R&D RMB 451m (1.8% rev).
| Item | 2024 |
|---|---|
| Raw materials | ~58% COGS |
| Energy | 6–8% COGS |
| Maintenance | CNY 420m |
| Marketing | RMB 1.12bn |
| Logistics | RMB 2.1bn |
| R&D | RMB 451m (1.8%) |
Revenue Streams
Sales of tissue paper products—toilet paper, facial tissues, and paper towels sold under brands like Hearttex—drive Hengan International Group’s largest revenue stream, accounting for roughly 62% of fiscal 2024 turnover (HKD 16.8 billion of HKD 27.1 billion). These high-frequency household buys sell via traditional retail and fast-growing e-commerce, with online sales rising ~28% year-on-year in 2024.
Hengan International earns high-margin revenue from feminine hygiene, with sanitary napkins and related products contributing roughly 28% of 2024 revenue (RMB 5.2 billion of total RMB 18.6 billion), driven by premium SKUs that grew 12% YoY and sustained brand loyalty; R&D in materials and pad design lifted ASPs and helped keep market share near 22% in China as of Q4 2024.
Revenue comes from sales of disposable diapers and baby-care items like wet wipes; Hengan reported baby-care segment sales of RMB 6.2 billion in 2024, about 28% of group revenue, driven by premium-priced lines and continuous product R&D (new anti-leak designs, skin-friendly materials). The firm prices across tiers to capture budget and premium buyers, keeping market share amid fierce competition from P&G and Johnson & Johnson.
Adult Incontinence and Personal Care Sales
Hengan’s adult incontinence and personal care sales are growing as China’s 65+ population hit 14.2% in 2023 and incontinence product demand rose ~8% CAGR (2021–24); Hengan uses its absorbent-material tech to serve elderly and medical markets, and this segment rose to about 12% of revenue in FY2024 and is forecast to rise further.
- China 65+ = 14.2% (2023)
- Incontinence product demand ≈ 8% CAGR (2021–24)
- Hengan adult-care ≈ 12% of revenue (FY2024)
International and Export Revenue
- 2024 int’l share: 8–10% (~RMB 1.2–1.5B)
- Primary markets: Southeast Asia
- Benefit: scale leverage, diversification
Core revenue: tissue products ~62% of FY2024 turnover (HKD 16.8B of HKD 27.1B); feminine hygiene ~28% (RMB 5.2B of RMB 18.6B); baby-care ~28% (RMB 6.2B); adult-care ~12% and rising; international ~8–10% (~RMB 1.2–1.5B).
| Stream | Share FY2024 | Amount |
|---|---|---|
| Tissue | 62% | HKD 16.8B |
| Feminine | 28% | RMB 5.2B |
| Baby-care | 28% | RMB 6.2B |
| Adult-care | 12% | — |
| International | 8–10% | RMB 1.2–1.5B |